TY - JOUR
T1 - Preserved cerebral oxygenation with worsening global myocardial strain during pediatric chronic hemodialysis
AU - Idrovo, Alexandra
AU - Pignatelli, Ricardo
AU - Loar, Robert
AU - Nieuwsma, Asela
AU - Geer, Jessica
AU - Solomon, Catharina
AU - Swartz, Sarah
AU - Ghanayem, Nancy
AU - Akcan-Arikan, Ayse
AU - Srivaths, Poyyapakkam
N1 - Funding Information:
Funders: Casey Lee Ball Foundation, (Grant / Award Number: '32354-N4')
Funding Information:
Financial Disclosure: No S. Swartz reports Consultancy Agreements with Fresenius Medical Care North America; and Other Interests/Relationships via Renal Physicians Association NCAP (Nephrology Coverage Advocacy Program) in Jun 2018, Renal Physician Association PAL (Pediatric Advocacy Leadership) Forum in Jun 2019, Program sponsored by Education grant from Amgen awarded by the RPA for participation, Multi-center site PI for phase 3 study to investigate the safety and efficacy of PA21 (Velphoro) and calcium acetate (Phoslyra) sponsored by Vifor Fresensius Medical Care Renal Pharma funded Sept 2016-Oct 2019. A. Akcan Arikan reports Research Funding from NIH NIAID, Bioporto; Scientific Advisor or Membership with Pediatric Critical Care Medicine, editorial board, associate editor. The remaining authors declared no potential conflicts of interest with respect to the research, authorship and/or publication.
Funding Information:
2019, Program sponsored by Education grant from Amgen awarded by the RPA for participation, Multi-
Publisher Copyright:
Copyright © 2021 by ASN, Published Ahead of Print on 9/13/21, Accepted/Unedited Version
PY - 2021/11
Y1 - 2021/11
N2 - Background Cerebral and myocardial hypoperfusion occur during hemodialysis in adults. Pediatric patients receiving chronic hemodialysis have fewer cardiovascular risk factors, yet cardiovascular morbidity remains prominent. Methods We conducted a prospective observational study of pediatric patients receiving chronic hemodialysis to investigate whether intermittent hemodialysis is associated with adverse end organ effects in the heart or with cerebral oxygenation (regional O2 saturation [rSO2]). We assessed intradialytic cardiovascular function and rSO2, using noninvasive echocardiography to determine myocardial strain and continuous noninvasive near-infrared spectroscopy for rSO2. We measured changes in blood volume and central venous oxygen saturation (mCVO2) were pre-, mid-, and post-hemodialysis. Results The study included 15 patients (median age, 12 years; median hemodialysis vintage 13.2 [9, 24] months were included. Patients were asymptomatic. The rSO2 did not change during hemodialysis, whereas mCVO2 decreased significantly, from 73% to 64.8 %. Global longitudinal strain of the myocardium worsened significantly by mid-hemodialysis and persisted post-hemodialysis. The ejection fraction remained normal. Lower systolic blood pressure and faster blood volume change were associated with worsening myocardial strain; only blood volume change was significant in multivariate analysis (β coefficient, -0.3; 95% confidence interval [95% CI], ~0.38 to ~0.21; P=0.0001). Blood volume change was also associated with a significant decrease in mCVO2 (β coefficient 0.42; 95% CI, 0.07 to 0.76; P=0.001). Access, age, hemodialysis vintage, and ultrafiltration volume were not associated with worsening strain. Conclusions Unchanged rSO2 suggested that cerebral oxygenation was maintained during hemodialysis. However, despite maintained ejection fraction, intradialytic myocardial strain worsened in pediatric hemodialysis and was associated with blood volume change. The effect of hemodialysis on individual organ perfusion in pediatric versus adult patients receiving hemodialysis might differ.
AB - Background Cerebral and myocardial hypoperfusion occur during hemodialysis in adults. Pediatric patients receiving chronic hemodialysis have fewer cardiovascular risk factors, yet cardiovascular morbidity remains prominent. Methods We conducted a prospective observational study of pediatric patients receiving chronic hemodialysis to investigate whether intermittent hemodialysis is associated with adverse end organ effects in the heart or with cerebral oxygenation (regional O2 saturation [rSO2]). We assessed intradialytic cardiovascular function and rSO2, using noninvasive echocardiography to determine myocardial strain and continuous noninvasive near-infrared spectroscopy for rSO2. We measured changes in blood volume and central venous oxygen saturation (mCVO2) were pre-, mid-, and post-hemodialysis. Results The study included 15 patients (median age, 12 years; median hemodialysis vintage 13.2 [9, 24] months were included. Patients were asymptomatic. The rSO2 did not change during hemodialysis, whereas mCVO2 decreased significantly, from 73% to 64.8 %. Global longitudinal strain of the myocardium worsened significantly by mid-hemodialysis and persisted post-hemodialysis. The ejection fraction remained normal. Lower systolic blood pressure and faster blood volume change were associated with worsening myocardial strain; only blood volume change was significant in multivariate analysis (β coefficient, -0.3; 95% confidence interval [95% CI], ~0.38 to ~0.21; P=0.0001). Blood volume change was also associated with a significant decrease in mCVO2 (β coefficient 0.42; 95% CI, 0.07 to 0.76; P=0.001). Access, age, hemodialysis vintage, and ultrafiltration volume were not associated with worsening strain. Conclusions Unchanged rSO2 suggested that cerebral oxygenation was maintained during hemodialysis. However, despite maintained ejection fraction, intradialytic myocardial strain worsened in pediatric hemodialysis and was associated with blood volume change. The effect of hemodialysis on individual organ perfusion in pediatric versus adult patients receiving hemodialysis might differ.
KW - Cerebral oxygenation
KW - Chronic hemodialysis
KW - Myocardial strain
KW - Pediatric
UR - http://www.scopus.com/inward/record.url?scp=85119043145&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85119043145&partnerID=8YFLogxK
U2 - 10.1681/ASN.2021020193
DO - 10.1681/ASN.2021020193
M3 - Article
C2 - 34518280
AN - SCOPUS:85119043145
SN - 1046-6673
VL - 32
JO - Journal of the American Society of Nephrology
JF - Journal of the American Society of Nephrology
IS - 11
ER -